FI71432C - Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner - Google Patents

Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner Download PDF

Info

Publication number
FI71432C
FI71432C FI814230A FI814230A FI71432C FI 71432 C FI71432 C FI 71432C FI 814230 A FI814230 A FI 814230A FI 814230 A FI814230 A FI 814230A FI 71432 C FI71432 C FI 71432C
Authority
FI
Finland
Prior art keywords
galactopyranosyl
composition according
component
moiety
macromolecular carrier
Prior art date
Application number
FI814230A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI814230L (fi
FI71432B (fi
Inventor
Kaellenius Gunilla Pettersson
Karl Arne Lundblad
Nils Roland Moellby
Stefan Birger Svensson
Jan Winberg
Original Assignee
Svenska Sockerfabriks Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FI824526A priority Critical patent/FI824526A0/fi
Application filed by Svenska Sockerfabriks Ab filed Critical Svenska Sockerfabriks Ab
Publication of FI814230L publication Critical patent/FI814230L/fi
Publication of FI71432B publication Critical patent/FI71432B/fi
Application granted granted Critical
Publication of FI71432C publication Critical patent/FI71432C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI814230A 1980-03-05 1981-12-31 Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner FI71432C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI824526A FI824526A0 (fi) 1980-03-05 1981-03-05 Anvaendning som aktiv bestaondsdel foer framstaellning av en farmaceutisk komposition av ett strukturelement, foeretraedesvis i terminalstaellning

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8001748A SE8001748L (sv) 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
SE8001748 1980-03-05
PCT/SE1981/000065 WO1981002520A1 (en) 1980-03-05 1981-03-05 Compositions for therapeutic or diagnostic use in connection with bacterial infections,and their use
SE8100065 1981-03-05

Publications (3)

Publication Number Publication Date
FI814230L FI814230L (fi) 1981-12-31
FI71432B FI71432B (fi) 1986-09-09
FI71432C true FI71432C (fi) 1986-12-19

Family

ID=20340427

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814230A FI71432C (fi) 1980-03-05 1981-12-31 Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner

Country Status (10)

Country Link
US (2) US4657849A (de)
EP (1) EP0035484B1 (de)
JP (1) JPH0322397B2 (de)
AT (1) ATE9062T1 (de)
AU (1) AU546148B2 (de)
DE (1) DE3165623D1 (de)
DK (2) DK489581A (de)
FI (1) FI71432C (de)
SE (1) SE8001748L (de)
WO (1) WO1981002520A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500609A (de) * 1980-05-09 1982-04-08
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
IL76981A (en) * 1985-11-07 1989-02-28 Univ Ramot Bacterially produced hetero polysaccharide dispersants for inorganic minerals in aqueous medium and their preparation
US5324828A (en) * 1986-12-11 1994-06-28 Genzyme Corporation 1-amino-1-deoxyoligosaccharides and derivatives thereof
US4942224A (en) * 1987-01-12 1990-07-17 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US4857639A (en) * 1987-01-12 1989-08-15 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US5167925A (en) * 1988-06-08 1992-12-01 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5112770A (en) * 1988-06-08 1992-05-12 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
DK0553113T3 (da) * 1990-08-02 1999-08-09 Antex Biolog Inc Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
FR2671100B1 (fr) * 1990-12-28 1993-03-05 Bio Merieux Procede d'analyse bacteriologique, et milieu de detection des bacteries genre salmonella.
EP0610356B1 (de) * 1991-10-18 2001-01-31 SYNSORB Biotech Inc. Behandlung bakterieller dysenterie
AU6663294A (en) * 1993-05-14 1994-12-12 Upjohn Company, The Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
US5910570A (en) * 1995-11-13 1999-06-08 Pharmacia & Upjohn Company Cloned DNA encoding a UDP-GalNAc: polypeptide N-acetylgalactosaminy-ltransferase
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
CA2326618A1 (en) * 1998-04-15 1999-10-21 Baxter International Inc. Inhibition of xenoreactive antibodies
JP3772204B2 (ja) * 2000-06-05 2006-05-10 独立行政法人産業技術総合研究所 糖鎖誘導体及びその製造方法
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) * 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1910715A1 (de) * 1968-03-04 1969-10-09 Stanley Drug Products Inc Antimikrobielle Faktoren und deren Verwendung
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2422681A1 (fr) * 1978-04-10 1979-11-09 Anvar Procede de preparation de derives d'osides, les nouveaux derives d'osides obtenus et leurs applications biologiques

Also Published As

Publication number Publication date
DK489581A (da) 1981-11-04
FI814230L (fi) 1981-12-31
AU6779581A (en) 1981-09-23
EP0035484A3 (en) 1981-09-16
JPH0322397B2 (de) 1991-03-26
WO1981002520A1 (en) 1981-09-17
US4762824A (en) 1988-08-09
JPS57500194A (de) 1982-02-04
DK75787D0 (da) 1987-02-13
US4657849A (en) 1987-04-14
FI71432B (fi) 1986-09-09
SE8001748L (sv) 1981-09-06
DE3165623D1 (en) 1984-09-27
EP0035484B1 (de) 1984-08-22
DK75787A (da) 1987-02-13
EP0035484A2 (de) 1981-09-09
ATE9062T1 (de) 1984-09-15
AU546148B2 (en) 1985-08-15

Similar Documents

Publication Publication Date Title
FI71432C (fi) Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner
EP0089938B1 (de) Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
Källenius et al. Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli
Sharon et al. Bacterial adherence to cell surface sugars
Striker et al. Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli
JPS61500355A (ja) グラム陰性菌のエンドトキシンに対するモノクロナ−ル抗体
FI69639C (fi) Preparat foer anvaendning vid klamydia-diagnostik
EP0089939A1 (de) Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
EP0089940A1 (de) Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
US5696000A (en) Adhesion receptors for pathogenic or opportunistic microorganisms
WO1986005789A1 (en) Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
EP3286200B1 (de) Chemische fluoreszente sonden zur detektion von biofilmen
Eder et al. Blood group antigens as receptors for pathogens
SE468231B (sv) Foerfarande foer att paavisa smaacelligt lungcarcinomantigen och anvaendning av antikroppar mot fukosylsialosylgangliotetraos foer framstaellning av komposition foer behandling eller in vivo/ diagnos
NO161644B (no) Preparater for in vitro diagnostisk bruk.
Morgenstern et al. Immunogenic cross-reactivity between human tissues and the enterobacterial common antigen
Gu et al. Antigenic components of Actinobacillus actinomycetemcomitans lipopolysaccharide recognized by sera from patients with localized juvenile periodontitis
EP1232754B1 (de) Verwendung von kationischen Helixpeptiden zur Behandlung von Sepsis und zur Bestimmung und Entfernung von Endotoxinen
Ferenčík Antigens
WO2000045173A1 (en) Inhibitors of intimin adhesion and tests for their screening
URBASCHEK et al. Deutsche Gesellschaft fur Hygiene und Mikrobiologie
NETUSCHIL et al. fiir Hygiene und Mikrobiologie, Section II, Mainz, Federal Republic of Germany, 23.-25. September 1982
HK1133267A1 (en) Enterococcus faecalis and/or enterococcus faecium antigen
JPH1081627A (ja) 血液凝固促進剤

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SVENSKA SOCKERFABRIKS AB